Ge Healthcare Techs (GEHC) closed at $83.02 on November 13, 2026, up 1.4% from the previous close, on volume of 2,226,305 shares (30-day average 3,948,056).
Data as of November 13, 2026.
13-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Nov 6, 2026 | Call Spread | 20-Nov-2677 : 83 C | 3,000 |
| 2-3 | The next 2 largest trades are for Premium members. Start a 7-day free trial | |||
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 13, 2026. See the 10 largest for 30, 60 and 90 days
TipRanks (Wed, 11-Nov 9:40 AM ET)
GE HealthCare to establish neuroscience research network
Seeking Alpha News (Tue, 10-Nov 9:11 AM ET)
Business Wire (Tue, 10-Nov 8:00 AM ET)
Business Wire (Tue, 3-Nov 9:00 AM ET)
Business Wire (Sun, 1-Nov 12:35 PM ET)
GE HealthCare raises 2026 outlook after 6.2% organic revenue growth and a 16.6% adjusted EBIT margin
Market Chameleon (Wed, 28-Oct 3:10 AM ET)
GE HealthCare reports third quarter 2026 financial results
Business Wire (Wed, 28-Oct 6:20 AM ET)
Business Wire (Tue, 20-Oct 12:39 PM ET)
Business Wire (Mon, 19-Oct 9:00 AM ET)
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
Ge Healthcare Techs trades on the NASDAQ stock market under the symbol GEHC.
As of November 13, 2026, GEHC stock price climbed to $83.02 with 2,226,305 million shares trading.
GEHC has a beta of 0.46, meaning it tends to be less sensitive to market movements. GEHC has a correlation of 0.03 to the broad based SPY ETF.
GEHC has a market cap of $37.50 billion. This is considered a Large Cap stock.
Last quarter Ge Healthcare Techs reported $6 billion in Revenue and $1.34 earnings per share. This beat revenue expectation by $159 million and exceeded earnings estimates by $.13.
In the last 3 years, GEHC traded as high as $94.80 and as low as $57.65.
The top ETF exchange traded funds that GEHC belongs to (by Net Assets): VTI, QQQ, VOO, VO, IVV.
GEHC has underperformed the market in the last year with a return of +12.4%, while SPY returned +13.4%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in GEHC shares. However, GEHC has outperformed the market in the last 3 month and 2 week periods, returning +12.6% and +8.4%, while SPY returned -2.8% and -0.2%, respectively. This indicates GEHC has been having a stronger performance recently.
GEHC support price is $80.04 and resistance is $83.64 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that GEHC shares will trade within this expected range on the day.
